CiplaCIPLA

CIPLACipla₹1,350.8▼ 2.35% today

Nifty 50

Cipla is a major pharmaceutical company with a strong respiratory franchise.

Key products	Generics, respiratory inhalers, APIs, consumer health.
Geography	India, US, South Africa and emerging markets.
Competitors	Sun Pharma, Dr Reddy's, Lupin.

AI-generated overview — verify before relying on it.

Net institutional flow

+₹1,527.1 Cr

Institutional buyers

21 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Rs 13 Per Share

ex 2026-06-05

Competitive landscape — the read

vs mapped peers · 3M

1M 3M 6M 1Y 2Y All

Institutional money is backing ALKEM hardest (+₹1,013.7 Cr net). CIPLA ranks #2 of 9 on flow (net buying +₹0 Cr). Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.

#	Company	Inst. flow ₹Cr	Deals	Hi-impact	Filing mom.	Buzz	News
1	ALKEM	+₹1,013.7 Cr	13	—	—	-2	6
2	CIPLAThis	—	—	—	—	+19	44
3	DRREDDY	—	—	—	—	+20	46
4	SUNPHARMA	—	—	—	—	+15	45
5	TORNTPHARM	—	—	—	—	—	—
6	LUPIN	—	—	—	—	—	—
7	ZYDUSLIFE	—	—	1	+1	—	—
8	AUROPHARMA	—	—	—	—	—	—
9	MANKIND	—	—	—	—	—	—

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — CIPLA day by day

1M 3M 6M 1Y 2Y All

2026-06-17NewsCipla appoints Shivam Puri as CEO of One India BusinessTopic · India
2026-06-16FilingCipla Limited has informed the Exchange regarding 'Grant Of Stock Options and Employee Stock Appreciation RighUpdates
2026-06-16FilingCipla Limited has informed the Exchange about change in ManagementChange in Management
2026-06-16NewsCipla Appoints Shivam Puri as CEO of One India BusinessTopic · India
2026-06-16NewsCipla appoints Shivam Puri as CEO, One India BusinessTopic · India
2026-06-16NewsCipla appoints Shivam Puri as CEO of One India BusinessTopic · India
2026-06-16NewsCipla arm names Shivam Puri CEO of One India Business, effective 1 July 2026Topic · India
2026-06-16NewsCipla expands respiratory, specialty manufacturing across India, China, USTopic · India
2026-06-16NewsCipla appoints Shivam Puri as CEO of One India BusinessTopic · India
2026-06-16NewsCipla Health Strengthens Tobacco Awareness DriveTopic · India
2026-06-16NewsCipla names Shivam Puri to lead India business in key consumer-to-core pharma leadership moveTopic · India
2026-06-16NewsCipla appoints Shivam Puri as CEO-One India BusinessTopic · India
2026-06-16NewsCipla Appoints Shivam Puri as CEO – One India Business, Effective July 1scanx.trade
2026-06-16NewsCipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rulesMoneycontrol.com
2026-06-16NewsCipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rulesMoneycontrol.com
2026-06-16NewsCipla appoints health chief Shivam Puri to lead One India businessTopic · India
2026-06-15NewsSun Pharmaceutical Industries Ltd Stock (INE044A01036): India pharma heavyweight in focus after receTopic · Generics
2026-06-15NewsCipla Share Price Live Chart Cipla News Today CIPLA Stock Price Charts Canadiens De Montréal (pTLxtVHFKS)Fathom Journal
2026-06-15NewsCIPLA SHARE PRICE ANALYSIS | CIPLA SHARE PRICE LATEST NEWS | CIPLA STOCK LATEST ANALYSIS Dow Jones Stock MarkeFathom Journal
2026-06-14NewsParag Parikh Flexi Cap Fund : ITC, HDFC Bank and Cipla among stocks bought and sold in MayThe Economic Times
2026-06-12NewsIndia’s pharma role is expanding beyond genericsTopic · Generics
2026-06-12NewsStocks to Watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL and moreBusiness Standard
2026-06-11FilingCipla Limited has informed the Exchange about USFDA inspection at Company s manufacturing facility in Verna, GGeneral
2026-06-09FilingCipla Limited has informed the Exchange about corrigendum to the intimation dated 1st June, 2026 regarding NoMeeting
2026-06-08FilingCipla Limited has informed the Exchange about communication on tax deduction at source on final dividend for FDividend
2026-06-05ActionDividend - Rs 13 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

2
UpdatesNeutral
Grant Of Stock Options and Employee Stock Appreciation Rights'.
Source PDF →
2
Change in ManagementNeutral
change in Management
Source PDF →
2
GeneralNeutral
USFDA inspection at Company s manufacturing facility in Verna, Goa, India
Source PDF →
2
MeetingNeutral
corrigendum to the intimation dated 1st June, 2026 regarding Notice of the 90th Annual General Meeting ( AGM ) along with Integrated Annual Report for FY 2025-26
Source PDF →
3
DividendNeutral
Tax info on dividend communicated.
Source PDF →